Table of Contents
Preface
Part 1: Historical Overview and the Evolution of Digital Health
Technologies
Chapter 1: A Brief History of Biomedical Products Regulation
Chapter 2: Medical Benefit-Risk Determination
Chapter 3: Medical Ethics Models and Frameworks in Digital
Health
Chapter 4: The Evolution of Digital Technologies in Healthcare
Chapter 5: Pulse Oximetry in Anesthesia -- The "Perfect" Medical
Technology Use Case
Chapter 6: The Technology of Biotechnology and Big Data in
Medicines
Chapter 7: Electronic Health Records: Promises, Progress, and
Problems
Part 2: The Ten Toxicities of Digital Health
Chapter 8: Introducing the Ten Toxicities
Chapter 9: Adversary-Driven Toxicities
Chapter 10: Non-Adversary-Driven Toxicities
Part 3: Frameworks for Digital Risk and Threat Mitigation
Chapter 11: Modeling Cyber Threats as Medical Adverse Events
Chapter 12: Current State of Cyber Regulation: Understanding
Privacy vs. Security
Chapter 13: Cyber Time: The Key Advantage of the Adversary
Chapter 14: Quantifying Cyber Threat for Patients, Providers, and
Institutions
Chapter 15: Case Studies: Notable Healthcare Hacks and Lessons
Learned
Part 4: Digital Health -- Hope, Hype and Risk Mitigation in
Practice
Chapter 16: The "Smart" Clinic
Chapter 17: The Patient as a Mobile Healthcare Consumer
Chapter 18: Artificial Intelligence in Healthcare
Chapter 19: Virtual Health Assistants
Chapter 20: Wearables
Part 5: The Future of Digital Health Benefit-Risk Assessment and
Management
Chapter 21: 5 Mitigations for the 10 Toxicities
Eric Perakslis is Chief Science Officer at the Duke Clinical
Research Insititute, Professor in the Department of Population
Sciences at Duke School of Medicine, Lecturer in Biomedical
Informatics at Harvard Medical School and on the Board of Directors
of the Kidney Cancer Association and Vivli. He has previously
served as Chief Information Officer and Chief Scientist
(Informatics) at the U.S. Food and Drug Administration, Strategic
Advisor on
Innovation to Médécins Sans Frontières and internationally as Chief
Information Officer of the King Hussein Institute for Biotechnology
and Cancer in Amman, Jordan.
Martin Stanley leads the Strategic Technology Branch at the
Cybersecurity and Infrastructure Security Agency (CISA). He has
previously led the Cybersecurity Assurance Program at CISA and the
Enterprise Cybersecurity Program at the U.S. Food and Drug
Administration, and held executive leadership positions at Vonage
and UUNET Technologies.
Erin Brodwin, health tech reporter and author.
"The promise of integrating digital technology and health care has
inspired hope for transformative change, while raising important
concerns around the privacy of our most personal information, and
how the management of these data will be secured and governed. In
this thoughtful, wise, and exceptionally grounded book, two of the
field's most experienced experts provide a rigorous and
comprehensive review of the challenges and opportunities, with a
pragmatic
focus on driving implementable change." -- David A. Shaywitz, MD,
PhD, Astounding HealthTech Advisory Services
"This book is an essential primer for anyone entering the digital
health space. As new technologies continue to reshape medicine and
health, we are all going to need to step back and assess where we
are and where we are likely to be. In this volume, Perakslis and
Stanley provide a starting point for getting smart on what is
current and what is to come in digital health." -- Michael
Stebbins, PhD, Former Biotechnology lead for the Obama White House
and President
of Science Advisors, LLC
![]() |
Ask a Question About this Product More... |
![]() |